In addition, it was noted that ubiquitin-specific peptidase 43 (USP43) could reduce the sensitivity of epithelial ovarian cancer cells to cisplatin by activating the Wnt/β-catenin signalling pathway [80]. This evidence concerns the gene USP43 and ovarian carcinoma.